https://pharmadog.xyz/news/209355 pharmadog en 2026-08-08T10:00:08.000Z Weekly roundup: Experts debate China biotech work ethic and a stalled megamerger https://pharmadog.xyz/news/207105 pharmadog en 2026-08-07T23:01:00.000Z Lexunder’s Food to Live green powder recalled over possible Salmonella contamination https://pharmadog.xyz/news/205288 pharmadog en 2026-08-07T17:33:09.000Z Senate hearings blame China, not Fauci, for Covid-19 origin delays https://pharmadog.xyz/news/205076 pharmadog en 2026-08-07T16:38:27.000Z EpilepsyGTx appoints Teresa Nunes as chief medical officer https://pharmadog.xyz/news/204983 pharmadog en 2026-08-07T16:35:22.000Z Senate introduces BINSA bill to tighten review of China biotech and pharma transactions https://pharmadog.xyz/news/205077 pharmadog en 2026-08-07T16:31:41.000Z NIH to restrict Pathways to Independence grants to U.S. citizens and permanent residents https://pharmadog.xyz/news/134233 pharmadog en 2026-08-07T16:10:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/204984 pharmadog en 2026-08-07T16:08:57.000Z FDA schedules September advisory panel to review Grail's cancer test after trial miss https://pharmadog.xyz/news/204712 pharmadog en 2026-08-07T15:08:24.000Z BioMarin halts development of BMN401 enzyme therapy after mixed Phase 3 results https://pharmadog.xyz/news/204559 pharmadog en 2026-08-07T15:00:01.000Z Pfizer exec says China's biotech growth will decelerate as firms hit R&D frontier https://pharmadog.xyz/news/204406 pharmadog en 2026-08-07T14:27:00.000Z Company issues corporate announcement on senior employee transaction https://pharmadog.xyz/news/204475 pharmadog en 2026-08-07T14:17:30.000Z Replimune secures FDA approval for Tudriqev, eyes $1.3 bn peak sales in advanced melanoma https://pharmadog.xyz/news/204515 pharmadog en 2026-08-07T14:02:00.000Z Revolution Medicines sees strong demand for pancreatic cancer drug daraxonrasib under compassionate use https://pharmadog.xyz/news/204307 pharmadog en 2026-08-07T13:56:04.000Z Biopharma job postings rise 15% in Q2 as layoffs fall and M&A activity picks up https://pharmadog.xyz/news/204199 pharmadog en 2026-08-07T13:18:05.000Z Eli Lilly and Novo Nordisk win dismissal of antitrust suit by compound pharmacy https://pharmadog.xyz/news/204819 pharmadog en 2026-08-07T13:00:09.000Z FDA grants emergency use authorization for CLiK Extra wound spray to prevent New World screwworm in livestock and wildlife https://pharmadog.xyz/news/204071 pharmadog en 2026-08-07T12:51:05.000Z Replimune secures FDA accelerated approval for melanoma therapy Tudriqev https://pharmadog.xyz/news/204051 pharmadog en 2026-08-07T12:48:29.000Z Intellia identifies HLA allele linked to severe liver enzyme spikes in ATTR gene therapy https://pharmadog.xyz/news/203934 pharmadog en 2026-08-07T12:16:46.000Z Third gender-affirming clinic settles with DOJ as Senate moves to hold Fauci in contempt https://pharmadog.xyz/news/203914 pharmadog en 2026-08-07T12:09:19.000Z Vistagen’s anxiety nasal spray fails to outperform placebo in Phase 2 study https://pharmadog.xyz/news/204091 pharmadog en 2026-08-07T12:00:00.000Z Latigo Biotherapeutics raises $345.6M in IPO to fund non-opioid pain drug pipeline https://pharmadog.xyz/news/203982 pharmadog en 2026-08-07T11:54:00.000Z Senior staff purchase company shares, filing 16/2026 shows insider buying https://pharmadog.xyz/news/203495 pharmadog en 2026-08-07T11:00:07.000Z Johnson & Johnson’s Global Chair of Innovative Medicine Jennifer Taubert Announces Retirement https://pharmadog.xyz/news/204662 pharmadog en 2026-08-07T10:59:00.000Z Ensoma cuts staff again to focus on lead gene therapy for rare immune disease https://pharmadog.xyz/news/204663 pharmadog en 2026-08-07T10:39:00.000Z BlossomHill and Latigo Biotherapeutics raise over 30% beyond IPO targets https://pharmadog.xyz/news/204130 pharmadog en 2026-08-07T08:59:00.000Z BioMarin halts development of BMN 401 after phase 3 miss https://pharmadog.xyz/news/204132 pharmadog en 2026-08-07T08:45:00.000Z Novo Nordisk CFO sees oral Wegovy rollout boosting outlook and remains upbeat on CagriSema https://pharmadog.xyz/news/202963 pharmadog en 2026-08-07T08:39:12.000Z BlossomHill and Latigo close IPO week with $496 million raised https://pharmadog.xyz/news/203007 pharmadog en 2026-08-07T08:30:00.000Z AI will further erode physician autonomy, says former surgeon https://pharmadog.xyz/news/203008 pharmadog en 2026-08-07T08:30:00.000Z Active shooter incident forces CDC staff to shelter in place, highlighting ongoing threats to public health workers https://pharmadog.xyz/news/203009 pharmadog en 2026-08-07T08:30:00.000Z Boston-born biotech founder Felix Wong launches AI-driven startup in California https://pharmadog.xyz/news/204003 pharmadog en 2026-08-07T06:51:00.000Z Roche launches cyclospora PCR tests as lettuce-linked outbreak spreads across 15 US states https://pharmadog.xyz/news/207637 pharmadog en 2026-08-07T00:00:00.000Z EMA releases updated guidance on drug shortage prevention plans https://pharmadog.xyz/news/207638 pharmadog en 2026-08-07T00:00:00.000Z FDA outlines inspection overhaul, proposes IND reforms, and greenlights a disputed cancer therapy https://pharmadog.xyz/news/200611 pharmadog en 2026-08-06T21:00:00.000Z Replimune's oncolytic virus therapy Tudriqev receives FDA accelerated approval for advanced melanoma https://pharmadog.xyz/news/200571 pharmadog en 2026-08-06T20:32:40.000Z Replimune’s Tudriqev immunotherapy receives FDA accelerated approval for advanced melanoma https://pharmadog.xyz/news/200359 pharmadog en 2026-08-06T20:03:38.000Z Replimune secures FDA accelerated approval for melanoma therapy after two prior rejections https://pharmadog.xyz/news/200423 pharmadog en 2026-08-06T19:59:28.000Z FDA grants accelerated approval to Replimune’s melanoma therapy Tudriqev after two prior rejections https://pharmadog.xyz/news/200699 pharmadog en 2026-08-06T19:56:59.000Z FDA grants accelerated approval to Tudriqev viral therapy for PD-1-refractory advanced melanoma